Tuberculosis Diagnostics Market

Tuberculosis Diagnostics Market by Test Types (Diagnostic Laboratory Method, Phage Assay, Radiographic Method, Detection of Latent Infection, Nucleic Acid Testing, and Drug Resistance Detection) and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021-2028

  • Report ID: HC-1915
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 2
  • No. Of Pages: 210
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global tuberculosis diagnostic market size is projected to register a substantial CAGR during the forecast period, 2021-2028 due to a high increase in the number of cases and is becoming a major healthcare burden due to its highly contagious nature. As the disease is a high burden, the government and other health agencies are largely concerned due to rapid increase in the demand for a quick diagnosis and effective treatment of the disease.

Tuberculosis Diagnostics Market Key Takeaways

Tuberculosis (TB) is a deadly bacteria-based and highly contagious infectious disease that severely affects the lungs as the bacteria spreads when individual sneezes or coughs. Majorly, people affected with TB do not show any symptoms in general but some of the common symptoms can be fever, night sweats, and weight loss. A global report by the World Health Organization (WHO) on TB states that 9.6 billion people were estimated to be infected by the disease among which 1.5 million deaths were caused. Another WHO’s report suggests that 2.64 million cases were registered for TB in India alone. As a result of which, governments and several health organizations are taking various initiatives to control the spread of the disease. For example, screening for the disease along with free access to diagnosis and treatment programs for TB is provided by the Revised National Tuberculosis Control Program (RNTCP) in India.

Advanced methods for diagnosis such as Interferon-gamma Release Assay (IGRA), cytokine detection assay, and serological tests, which are widely adopted during the emergency. These tests are considered to be offering accurate results within a short period of time with the usage of a small amount of biological samples. Several diagnosis requirements are being fulfilled with the development of Point of Care (PoC) methods including TB lipoarabinomannan antigen test by Alere, Inc. and Xpert MTB/RIF assay by Cepheid. These diagnostic devices considered to be cost-effective, simple to use, and provide quick and accurate results.

Market Trends, Drivers, Restraints, and Opportunities

  • Growth in the elderly population is expected to boost the market growth as people above the age of 60 are most likely to be infected by TB.
  • Rise in various initiatives taken by governments to promote the diagnosis of TB by understanding the gaps for the management of tuberculosis is a driving factor of the market.
  • Increase in the investments made for research & development and product pipelines are expected to fuel the market expansion in the coming years.
  • Increase in the demand for PoC in healthcare facilities along with advancements in technology is a major factor propelling the growth of the market.
  • High price of diagnostics test and the low coverage of health insurance are key restraining factors hindering the market growth.

Scope of the Report

The report on the global tuberculosis diagnostic market includes an assessment of the market, trends, and segments. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Tuberculosis Diagnostics Market – Global Industry Analysis, Growth, Share, Size, Trends, And Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Test Types (Diagnostic Laboratory Method, Phage Assay, Radiographic Method, Detection of Latent Infection, Nucleic Acid Testing, and Drug Resistance Detection)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

QIAGEN; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc., Becton; Hologic Corp; bioMerieux SA; Abbott Laboratories; Alere Inc.; Dickinson and Co.; Hain Lifescience GmbH; Cepheid; and Sanofi

Market Segment Insights

Nucleic acid testing & detection of latent infection segment is expected to register a robust growth rate

On the basis of test types, the global tuberculosis diagnostics market is divided into diagnostic laboratory methods, phage assay, radio graphic method, detection of latent infection, nucleic acid testing, and drug resistance detection. The diagnostic laboratory method segment held a key share of the market in 2019 owing to an increase in the incidence of TB cases and wide adoption of the testing kits for laboratory experimental purposes. However, nucleic acid testing & detection of latent infection is expected to register a robust growth rate during the forecast period owing to their high usage as the diagnostic tools for the disease. Furthermore, drug resistance detection is anticipated to expand at a steady rate.

Tuberculosis Diagnostics Market By Test Types

Asia Pacific is estimated to exhibit lucrative growth

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia Pacific held a dominant market share in 2019 and is estimated to exhibit lucrative growth during the forecast period. According to the world report published in 2015 countries such as India, China, Bangladesh, Indonesia, and Afghanistan has the highest number of cases as a result of which various initiatives have been taken by the local government and the World Health Organization (WHO). Some of the programs that were planned by the local health agencies are the Revised National Tuberculosis Control Program (RNTCP) in India, Infectious and Endemic Disease Control in China, and the National TB program in Afghanistan. On the other hand, Latin America and Europe are expected to attain a significant growth rate during the forecast period.

Tuberculosis Diagnostics Market By Regions

Segments

Segments Covered in the Report
The global tuberculosis diagnostics market has been segmented on the basis of

Test Types
  • Diagnostic Laboratory Method
  • Phage Assay
  • Radiographic Method
  • Detection of Latent Infection
  • Nucleic Acid Testing
  • Drug Resistance Detection
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • QIAGEN
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific Inc.
  • Becton
  • Hologic Corp
  • bioMerieux SA
  • Abbott Laboratories
  • Alere Inc.
  • Dickinson and Co.
  • Hain Lifescience GmbH
  • Cepheid
  • Sanofi.

Competitive Landscape

Key players competing in the global tuberculosis diagnostics market are QIAGEN; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc., Becton; Hologic Corp; bioMerieux SA; Abbott Laboratories; Alere Inc.; Dickinson and Co.; Hain Lifescience GmbH; Cepheid; and Sanofi. Many of these players have adopted business strategies such as the launch of new products, the advancement of technologies, mergers, partnerships, and production capacity expansion to increase their market position and expand their consumer base globally. For example, Alfa Aesar was acquired by Thermo Fisher Scientific, Inc. in 2015.

Tuberculosis Diagnostics Market By Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Tuberculosis Diagnostics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Tuberculosis Diagnostics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Tuberculosis Diagnostics Market - Supply Chain
  4.5. Global Tuberculosis Diagnostics Market Forecast
     4.5.1. Tuberculosis Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Tuberculosis Diagnostics Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Tuberculosis Diagnostics Market Absolute $ Opportunity
5. Global Tuberculosis Diagnostics Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Tuberculosis Diagnostics Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Tuberculosis Diagnostics Demand Share Forecast, 2019-2026
6. North America Tuberculosis Diagnostics Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Tuberculosis Diagnostics Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Tuberculosis Diagnostics Demand Share Forecast, 2019-2026
7. Latin America Tuberculosis Diagnostics Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Tuberculosis Diagnostics Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Tuberculosis Diagnostics Demand Share Forecast, 2019-2026
8. Europe Tuberculosis Diagnostics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Tuberculosis Diagnostics Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Tuberculosis Diagnostics Demand Share Forecast, 2019-2026
9. Asia Pacific Tuberculosis Diagnostics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Tuberculosis Diagnostics Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Tuberculosis Diagnostics Demand Share Forecast, 2019-2026
10. Middle East & Africa Tuberculosis Diagnostics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Tuberculosis Diagnostics Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Tuberculosis Diagnostics Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Tuberculosis Diagnostics Market: Market Share Analysis
  11.2. Tuberculosis Diagnostics Distributors and Customers
  11.3. Tuberculosis Diagnostics Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. QIAGEN F. Hoffmann-La Roche AG Thermo Fisher Scientific Inc. Becton Hologic Corp bioMerieux SA  
Segments Covered in the Report
The global tuberculosis diagnostics market has been segmented on the basis of

Test Types
  • Diagnostic Laboratory Method
  • Phage Assay
  • Radiographic Method
  • Detection of Latent Infection
  • Nucleic Acid Testing
  • Drug Resistance Detection
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • QIAGEN
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific Inc.
  • Becton
  • Hologic Corp
  • bioMerieux SA
  • Abbott Laboratories
  • Alere Inc.
  • Dickinson and Co.
  • Hain Lifescience GmbH
  • Cepheid
  • Sanofi.

Key players competing in the global tuberculosis diagnostics market are QIAGEN; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc., Becton; Hologic Corp; bioMerieux SA; Abbott Laboratories; Alere Inc.; Dickinson and Co.; Hain Lifescience GmbH; Cepheid; and Sanofi. Many of these players have adopted business strategies such as the launch of new products, the advancement of technologies, mergers, partnerships, and production capacity expansion to increase their market position and expand their consumer base globally. For example, Alfa Aesar was acquired by Thermo Fisher Scientific, Inc. in 2015.

Tuberculosis Diagnostics Market By Key Players

Buy Report